Why Bio Protocol (BIO) is Up 200% in The Last 14 Days?

Key Points:

• $BIO surged 200% in 14 days, fueled by upgrades and investments.
• Over 125M tokens staked after V2 Launchpad and BioXP rollout.
• Coinbase listing and Arthur Hayes’ $1M investment boosted market momentum.

Bio Protocol’s token ($BIO) has risen more than 200% in the last 14 days, propelled by a combination of technical upgrades, exchange listings, and high-profile investments.

More than 125 million tokens have been staked, volumes have exceeded $420 million, and the price has climbed from $0.065 to over $0.2 since late July 2025.

125M $BIO Staked After V2 Launchpad and BioXP Rollout

The rally began in late July 2025, when Bio Protocol introduced its V2 Launchpad alongside BioXP, a points system designed to reward staking and community engagement. The update also deployed BioAgents, AI tools aimed at automating parts of the scientific research process.

According to on-chain data reported by Token Metrics on X, more than 125 million $BIO tokens were staked following the launch, a 400% increase compared to previous levels, which reduced circulating supply, creating upward pressure on the token’s price and feeding into a cycle of higher staking, rising prices, and increased participation.

Coinbase Listing, $1M Hayes Investment Boost Bio Protocol

In July 2025, $BIO was listed on Coinbase, expanding access to retail investors. The project has also attracted notable backers. Binance Labs announced investment in November 2024, and recent on-chain records reportedly confirm that Arthur Hayes, co-founder of BitMEX, invested $1 million.

Bio Protocol has previously partnered with VitaDAO, Pfizer Ventures, and Harvard Medical School, strengthening its position in the DeSci ecosystem.

$BIO Jumps 25% After $80K Clinical Trial Funding

Unlike many crypto projects, Bio Protocol connects its token directly to biotechnology research. The project recently allocated $80,000 to a Phase 2 clinical trial exploring treatments for brain health and memory improvement. Because $BIO holders are linked to royalties and intellectual property revenues from funded research, the token carries potential real-world value beyond speculation.

According to Stacy Muur, Founder Green Dots, the announcement had an immediate market impact. $BIO jumped 25% on the day of the funding news, with trading volumes surpassing $420 million, nearly double its market capitalization at that time.

$BIO Hits $0.20 as Volume Surpasses $580 Million

In the days leading up to the upgrade, $BIO traded between $0.056 and $0.081, with daily volumes below $100 million. After the staking program went live, the price reached $0.129 and volumes spiked as high as $421 million.

The upward trajectory continued following Hayes’ investment, with $BIO peaking at $0.2 and daily volume exceeding $580 million, close to its $312 million market cap.

Bio Protocol currently supports 12 BioDAOs, with over $24.3 million raised and $15 million deployed into scientific research. Its model of linking token value to biotech intellectual property distinguishes it within the DeSci sector.